Compulsory Licensing and Other Government Actions: To Use or Not To Use? (RECORDING)
Most countries in the world have enacted statutory compulsory licensing provisions or other government measures to promote domestic innovation or the domestic economy, protect national security, allocate the government’s rights in federally funded inventions and/or to address public emergencies. During the last year there has been renewed focus on the extent to which governments should assume patent licensing powers to make crucial medical related supplies available (e.g., medicines, vaccines and PPEs). The webinar will explore this issue from a legal and policy perspective, and discuss the voluntary IP licensing initiatives taken by companies in the pharmaceutical, medical device and IT industries in meeting the challenges of the current pandemic.
VP and Associate Chief Intellectual Property Counsel
3M Innovative Properties Co.
Colene Blank has been IP Counsel at 3M since 2000. She has represented divisions as diverse as Industrial Tapes, Commercial Graphics, and Renewable Energy. In 2011, she was elevated to the Assistant Chief Intellectual Property Attorney for the Display and Graphics Business and moved to the Healthcare Business Group in 2013. In 2017, Colene began representing the Safety and Industrial Business Group. She graduated from the University Of San Francisco School Of Law in 1999 after completing her BS in Chemical Engineering at the University of California. After the California bar exam, she worked at Heller Ehrman White and McAuliffe in Palo Alto, California. As an Intellectual Property Counsel, Colene’s areas of practice have included filing and prosecuting patent applications, drafting and negotiating intellectual property agreements, managing patent litigation, drafting opinions on infringement and validity matters, assessing and integrating acquisitions, worldwide patent portfolio management, managing worldwide intellectual property budgets, and client counseling.
Thomas A. Brown
Senior Legal Director
Tom Brown is a Senior Legal Director at Dell, where he leads Dell’s talented intellectual property litigation team, and manages a docket of IP litigation and post-grant review proceedings. Tom has overseen scores of cases from inception through appeal, in the PTAB and in courts across the country. Intellectual property policy also forms a substantial component of Tom’s role at Dell, where he plays a leading role shaping and articulating Dell’s policy positions. In this capacity, Tom drafts and manages amicus briefs, PTO comments, and other advocacy designed to promote a balanced, effective, and efficient regime for the protection of intellectual property. Tom currently serves as chair of IPO’s Damages and Injunctions Committee and on the steering committee of the Sedona Conference Working Groups 9 and 10 on Patent Damages, Remedies, and Litigation. He is also the Counselor of the Alan D. Lourie Boston IP American Inn of Court. Before joining Dell, he was a litigation principal at Fish & Richardson, and was previously a software design engineer at Microsoft.
Senior Corporate Counsel
Sharon Reiche is the co-Chair of IPO’s International Patent Law & Trade Committee, and in this role she participated in IPO’s Special 301 comment process. She is also Chair of IPO’s Subcommittee on Compulsory Licenses and a member of IPO’s Pharmaceutical & Biotechnology Issues Committee and the Women in IP Law Committee. Sharon is Senior Corporate Counsel, Global Intellectual Property Policy & Advocacy, Pfizer Inc. In her role she leads a team that works on intellectual property policies that advance the protection of Pfizer’s substantial investment in research and development. She holds a B.S. from the University of Massachusetts, Amherst, and a J.D. from Brooklyn Law School. She is admitted to practice law in New York.